Ireland - English - HPRA (Health Products Regulatory Authority)

actelion registration ltd - epoprostenol - pdr for soln for infusion - 0.5 milligram - epoprostenol

Ireland - English - HPRA (Health Products Regulatory Authority)

actelion registration ltd - epoprostenol - pdr for soln for infusion - 1.5 milligram - epoprostenol

Israel - English - Ministry of Health

j-c health care ltd - macitentan - film coated tablets - macitentan 10 mg - macitentan - opsumit ® is an endothelin receptor antagonist (era) indicated for the treatment of pulmonary arterial hypertension (pah, who group i) to delay disease progression. disease progression included: death, initiation of intravenous (iv) or subcutaneous prostanoids or clinical worsening of pah (decreased 6-minute walk distance, worsened pah symptoms and need for additional pah treatment). opsumit also reduced hospitalization for pah.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actelion pharmaceuticals uk ltd - bosentan monohydrate - tablet - 62.5mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actelion pharmaceuticals uk ltd - bosentan monohydrate - tablet - 125mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actelion pharmaceuticals uk ltd - miglustat - capsule - 100mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actelion pharmaceuticals uk ltd - macitentan - tablet - 10mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actelion pharmaceuticals uk ltd - selexipag - tablet - 200microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actelion pharmaceuticals uk ltd - selexipag - tablet - 400microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actelion pharmaceuticals uk ltd - selexipag - tablet - 600microgram